• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Endocare

Endocare

Endocan Corp ENDO

Last Price$0.01Day Change (%)-14.44%
Open Price$0.01Day Change ($)0.00
Day Range0.01–0.0152-Week Range0.00–0.02

As of Tue 9/27/2016 11:59:00 AM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. UPDATE: U.S. stocks edge lower, but on pace for weekly gain

    UPDATE: U.S. stocks edge lower, but on pace for weekly gain

  2. MARKET SNAPSHOT: Stocks Sink To Session Lows As Oil Tanks, But Weekly Gains In Sight

    MARKET SNAPSHOT: Stocks Sink To Session Lows As Oil Tanks, But Weekly Gains In Sight

  3. UPDATE: Stocks sink to session lows as oil tanks, but weekly gains in sight

    UPDATE: Stocks sink to session lows as oil tanks, but weekly gains in sight

  4. MARKET SNAPSHOT: Stocks Sink To Session Lows As Oil Tanks, But Weekly Gains In Sight

    MARKET SNAPSHOT: Stocks Sink To Session Lows As Oil Tanks, But Weekly Gains In Sight

  5. UPDATE: Stocks sink as oil tanks, but weekly gains in sight

    UPDATE: Stocks sink as oil tanks, but weekly gains in sight

  6. Bovie J-Plasma® Precise 360™ Handpiece Named ‘Innovation of the Year’ by the Society of Laparoendoscopic Surgeons (SLS)

    Bovie J-Plasma® Precise 360™ Handpiece Named ‘Innovation of the Year’ by the Society of Laparoendoscopic Surgeons (SLS)

  7. The Market: Exaggerated Woes

    Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first half of 2008 because of lackluster Phase III trial results. The drug candidate failed to show statistically significant results for pain relief in ...

  8. Health Care: 3 Picks in a More Expensive Sector

    Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.

  9. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.